The secret to Germany's FP6 success

Germany took the opportunity to look back at its impressive performance in the Sixth Framework Programme (FP6) as it held a national launch event for FP7 in Bonn on 15 and 16 January.

Germany is ranked first among all participating countries for FP6. The latest available statistics from the European Commission show 7,449 German participations in 3,027 FP6 contracts, with a total EU contribution to German participants of around €2.3 billion. Overall, German researchers participated in 82% of FP6 projects and received nearly 19% of the overall FP6 budget. Proposals involving Germany also had a 24% success rate - significantly higher than the EU average of 18%.

These figures come as no surprise when one considers how much the country invests in its national research base. According to preliminary figures from Eurostat for 2005, Germany is one of the highest investors in research in Europe, spending 2.51% of its GDP on research and development (R&D). In 2007, the German Government says it will increase its funding for research to €10 billion.

However, the secret of Germany's success in FP6 does not lie in investment alone, but in the nature of the national research base, according to Klaus Uckel of the German Federal Ministry for Education and Research (BMBF). "For us the focus has been on creating excellence," he told CORDIS News, and by providing researchers with access to continued institutional and project support, whether it be at Länder (regional), federal or EU level.

Germany's approach to funding differs somewhat from that of other Member States. Mr Uckel pointed to the UK as an example, where researchers cannot apply for national funding if resources are available at EU level. "We didn't want to stress our scientists out by saying: "you will only get money at national level which you cannot get at EU level", explained Mr Uckel. He highlighted the potential dangers of cordoning off national funding in such a way. "This could lead to an even higher oversubscription of the framework programme budget and result in weakening scientific excellence overall: because what will these scientists do if their EU proposal is not successful or if the EU money runs out?" he asked.

The German 'open' funding mechanism is much more advantageous, believes Mr Uckel, since it helps to train researchers, giving them the experience they need in their field as well as acquainting them with the fine art of grant application. 'We always say that it is good training for young researchers to practice applying for grants first at national level and then based on the experience they obtained, to see whether they can go forward and apply for an EU grant,' he explained.

Also key to Germany's successful participation in FP6 is ensuring that the national research agenda reflects what is happening at EU level, and vice versa. "We are really trying to find coherence between the national and EU programmes. When we are planning the national thematic areas, we are paying close attention to the EU framework programme," said Mr Uckel. "That way those interested in participating in projects know at an early stage about our plans and what is on the agenda, both at national and EU level." Aligning national and EU thematic areas would appear to have paid off. According to Mr Uckel, Germany achieved success rates above the EU average in nearly all thematic areas of FP6, with the exception of food quality and safety.

Germany has also managed to bring onboard industry more successfully than many of the other participating countries. According to the latest statistics, there were as many participants in FP6 coming from German industry as there were from academia and public research institutes.

"The fact that industry is participating on an equal footing shows that the exchange or transfer of knowledge is very healthy in Germany," said Mr Uckel. During the planning of FP7, German industry stakeholders called for a greater focus on the needs and interests of industry.

"But this data is showing the framework programme has already been of interest to German industry. Industry themselves didn't realise they were participating to this extent. They are very happy with these indicators," said Mr Uckel. He believes the figures will further encourage industry partners to participate.

Helping the Education and Research Ministry to raise awareness of EU funding opportunities is the network of German national contact points (NCP), which has grown to cover both the thematic areas and horizontal areas of the framework programme. Mr Uckel believes that the network has been hugely instrumental in helping applicants to find their way through the complex application procedure, providing a lot of support on anything from legal and intellectual property rights (IPR) questions to responding to calls.

The NCP network has also significantly contributed to discussions on the structuring and content of FP7. "The ministry has taken a bottom-up approach to gain feedback on the thematic priorities and participants' experience of the framework programme. Thanks to this feedback, Germany was able to come up with suggestions to simplify the application procedures in FP7," explained Mr Uckel.

Looking towards FP7, Mr Uckel said that Germany, as one of the largest Member States, would be looking to help smaller countries in the Union to get involved in the framework programme. "As a big industrial country, Germany has social responsibility towards the new Member States," he said. Already in FP6, the ministry set up a Contact Point for the new Member States and accession countries and those researchers and institutes in Germany that are interested in working with partners from the Accession States.

As for Germany's own involvement, Mr Uckel says he is confident that his country will maintain its high performance, winning more project contracts. Judging by the number of researchers packing into the workshops at the FP7 launch event, Germany looks set for another successful framework programme.

For more information about Germany's R&D performance, please visit:
http://www.bmbf.de/en/index.php

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...